Literature DB >> 9138457

Review: immunobiology of preeclampsia.

R N Taylor1.   

Abstract

Preeclampsia has been recognized clinically since the time of Hippocrates: however its etiology and pathophysiology remain enigmatic. This pregnancy-specific syndrome typically presents in late pregnancy as hypertension, edema, and proteinuria. Investigations over the past 15 years have revealed that preeclampsia is associated with abnormal placentation, reduced placental perfusion, endothelial cell dysfunction, and systemic vasospasm. Since it occurs more commonly in primigravidae and in women with underlying collagen-vascular diseases, an immunological component has long been suspected. Increased prevalence in high-order and molar pregnancies and those associated with increased placental mass suggests that trophoblastic volume and fetal antigen load are correlated with the syndrome. Epidemiological reports indicate that the prevalence of preeclampsia is decreased in women who received heterologous blood transfusions, practiced oral sex, or when a long period of cohabitation preceded an established pregnancy. Conversely, the use of condoms as a primary mode of contraception is associated with a higher risk of preeclampsia. These studies suggest that prior exposure to foreign or paternal antigens imparts a protection against the likelihood of developing preeclampsia. Clinical evidence of cellular and humoral immune dysfunction is associated with the syndrome. Fibrin and complement deposition and "foam" cells in atherosis lesions resemble the histopathology of renal allograft rejection. Relative T-cell, natural killer cell, and neutrophil activation have been reported in preeclampsia and circulating cytokines and antiphospholipid antibodies are more prevalent in preeclampsia than in normal pregnant women. These abnormalities are consistent with the systemic endothelial cell dysfunction that has been postulated as a pathophysiological feature of preeclampsia. While such associations do not prove causality, they suggest testable hypotheses for continued basic and clinical investigation of this major complication of human pregnancy.

Entities:  

Mesh:

Year:  1997        PMID: 9138457     DOI: 10.1111/j.1600-0897.1997.tb00195.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  14 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

Review 3.  Normal and abnormal transformation of the spiral arteries during pregnancy.

Authors:  Jimmy Espinoza; Roberto Romero; Yeon Mee Kim; Juan Pedro Kusanovic; Sonia Hassan; Offer Erez; Francesca Gotsch; Nandor Gabor Than; Zoltan Papp; Chong Jai Kim
Journal:  J Perinat Med       Date:  2006       Impact factor: 1.901

4.  Lipid rafts and cytoskeletal proteins in placental microvilli membranes from preeclamptic and IUGR pregnancies.

Authors:  Gloria Riquelme; Catalina Vallejos; Nicole de Gregorio; Bárbara Morales; Valeria Godoy; Macarena Berrios; Noelia Bastías; Carolina Rodríguez
Journal:  J Membr Biol       Date:  2011-05-15       Impact factor: 1.843

5.  Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis.

Authors:  Jisook Park; Dong Hyun Cha; Soo Jae Lee; Young Nam Kim; Young Hwan Kim; Kwang Pyo Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

6.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 7.  Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection.

Authors:  Amret Hawfield; Barry I Freedman
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-11-04

8.  Pre-eclampsia: is it all in the placenta?

Authors:  Harbindar Jeet Singh
Journal:  Malays J Med Sci       Date:  2009-01

9.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.

Authors:  E K Moses; J A Lade; G Guo; A N Wilton; M Grehan; K Freed; A Borg; J D Terwilliger; R North; D W Cooper; S P Brennecke
Journal:  Am J Hum Genet       Date:  2000-10-17       Impact factor: 11.043

10.  (31)P and (1)h nuclear magnetic resonance spectroscopy of blood plasma in female patients with preeclampsia.

Authors:  Susanne Schott; Josef Hahn; Christian Kurbacher; Detlef Moka
Journal:  Int J Biomed Sci       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.